Ahmad Hardy is going off draft boards like a guy who plays in September. The latest word out of Columbia says he won't. If you're paying a top-six price for a back who opens the year on the sideline, you're paying for games he isn't going to give you.
The price
We have Hardy at No. 6 overall in our Preseason Top 50 — second running back on the board, one spot behind Isaac Brown. The next backs after him are Kewan Lacy at 10, Jadan Baugh at 13 and Nate Frazier at 14. That's the real cost of taking Hardy: you pass on three healthy RBs to do it.
The production earned that slot. Last year: a Missouri school-record 1,649 rushing yards and 16 touchdowns on 256 carries, about 6.4 a pop. He was a Doak Walker finalist. Missouri built the offense around him, and every preseason All-America list you can find has him on it. For a full season, No. 6 is fair. Maybe light.
The problem is the "full season" part.
The timeline
Hardy was shot in the upper leg at an outdoor concert in Laurel, Mississippi on May 10. Surgery the same day, then back to Columbia for rehab.
At SEC Media Days on July 20, Eli Drinkwitz said the bullet struck bone, the bone had completely healed, and Hardy was medically cleared to begin his return-to-play process. Read that sentence again. Cleared to begin. Not cleared to play. That distinction is doing a lot of work, and the coverage at the time treated Week 1 as a hope, not a plan.
Then the turn: the most recent report, Aug 23, has Hardy unavailable for the start of the season.
Look at the direction of travel — May surgery, July "cleared to begin," late August "not for the opener." Nothing in that sequence has ever pointed at a Week 1 snap. The market kept pricing him as if it did.
The arithmetic
Fantasy drafts don't score potential. Every week Hardy sits, your No. 6 pick puts up a zero while Lacy, Baugh and Frazier — the guys you passed on — bank points.
Call it two games missed and he's a top-six pick asked to win you the season over the back ten. Call it three and you're paying a first-round price for roughly three-quarters of a player, on a leg that stopped a bullet four months ago. Even the best case has a ramp-up: nobody comes off that kind of rehab and gets 20 touches in his first game back.
The honest read: Hardy is still the most talented back in this conversation, and if he returns in September and looks like himself, the second half of your season is elite. That's the case for. The case against is that you can get elite second halves from healthy backs at 10, 13 and 14 without eating the zeros first.
Fade at No. 6. If he slides into the back half of the second round in your league, that's a different conversation. At his current cost, let somebody else hold the bag through September.
The buy
Here's the part nobody is pricing. Missouri didn't stop being a run-first offense because its star is hurt. Those carries go somewhere, and in September they go to whoever is standing behind Hardy on the depth chart.
The name on the angle is Jamal Roberts. If the depth chart confirms him as the next man up, he's exactly the kind of back who gets forgotten in August and starts your RB2 slot in September — full volume, an offense designed to feed the position, and a draft cost that rounds to nothing. That's the trade: the market repriced Hardy the moment the injury news landed, and it never repriced the man taking his carries.
Weight room offense, open backfield, late-round price. That's a buy.
Verdict box
Ahmad Hardy — FADE at No. 6. Target: back of the second round or later, and only if you can afford dead weeks early. Do not draft him as your RB1.
Missouri's next man up (Jamal Roberts, pending depth chart) — BUY late. Target: last three rounds. Startable RB2 through September; a lottery ticket if Hardy's return drags.
The stake for Hardy is bigger than fantasy. He was a Doak Walker finalist and set the school rushing record; the 2026 version of that season, on a rebuilt leg, is the difference between "great Missouri back" and a name people say in the same breath as the best to ever do it there. September just isn't where that story starts.
Who you got — the record-setter on a timeline, or the healthy backs behind him?
